The relatively minor effect of the absence of LigI on protein dynamics at the replication fork is consistent with the cytostatic rather than cytotoxic activity of a LigI inhibitor34, suggesting that a LigI inhibitor will have limited toxic side-effects on normal tissues and cells but may have utility in the selective targeting of cancer cells with specific DNA repair defects20. Here, LIG1 is linked to cancer.